fun'ol/l)
r L), E; r -J-. )Lfe.\ttnt +7rr f..-/1. t,w*itlr. i.trll.tira-1.,. ti/.- 7.\ f J]!t) -. lin j(*j.7 j )r. t)t,, nll\a=t)atrt-rl, fti1,7i/,, -?at c ';- rr., )\i,.a;1t_ x'!',2,".7)r:-),lr'
(,,,- (nslmll r\uc. (ns.bnl) 16frg' C".. (ng'ml) AUC0. {sg h/st-l
ii: l..r8 mo I ithrf;&-\ fr 4,j-, ] 5 l,l ir it J J- r. Ffldeicd$-(11. lr. t,/d^':{r'!il I *
LOCE: Last obse.lation cafted fo.wa.d,4ilr LOCF: Last obsenarion car'ed fo^vard LO(]F : Lar obseraiion canied fors ard
= :1*7 B ): y t 2.25 mg Els y =f 4.5 mg Ft):vt9ng F-lll Y 7-13.5 mg
::L lj {'. *Zf6 2.5mg =, +3-2f,.f 5ms :
Tt) +.1--.R'ffiz sre 2.7nrm 3.8mm
T,':
3 v7 rvfrtn5mg
.1.9-1.5 96..1r 58.2 r -lf lz 92.3 + r06! It'lBZ 1a2+ 9.5 ';?fjl *'',0
^; -os f no* r: s
CyclogMil fnsls[)
BioMarin Pharmaceutical Inc.
B0T0X'tor iniection
74. s% <74/94) 3.0{i0.i99{6).0.6610.ti5(51)
n-! v /-rv
1r1t), t^r'trlwrj,rs4161tldd4itl:s L00 l0 82r ]??l l!{ngsp)alr FPc Meanr\D i!,";;i t--{'l''r j:;.s,.1t r i; "r['&t!t 'J' F.:r64t,:ztlr'ftne
7rt1a//r-
&l)tlr^t) i l xi 1415 n=6. 'F$ nd